A Feasibility and Registration Study of Proton Radiotherapy for Upper Gastrointestinal Malignancies
This protocol invites patients with cancer of the upper digestive tract who will receive
simultaneous proton radiation therapy and chemotherapy. The purpose of this study is to use
a newer form of radiation therapy called proton radiation and to determine if its use is
safe and effective in people with this type of cancer. Doctors will assess the safety of
this method of treatment, record the side effects participants experience while receiving
the standard dose of proton radiation.
Primary Purpose: Treatment
Serious Adverse Events
Patient is unable to tolerate more than 25% of treatments using proton radiotherapy.
John Plastaras, MD, PhD
Abramson Cancer Center of the University of Pennsylvania
United States: Institutional Review Board
|Abramson Cancer Center of the University of Pennsylvania||Philadelphia, Pennsylvania 19104-4283|